Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125809131 | 12580913 | 1 | I | 2013 | 20160711 | 20160721 | 20160721 | PER | US-ELI_LILLY_AND_COMPANY-US201607004683 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125809131 | 12580913 | 1 | PS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 40 U, TID | 20563 | 40 | IU | INJECTION | TID | ||||||
| 125809131 | 12580913 | 2 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 40 U, TID | C506933E | 20563 | 40 | IU | INJECTION | TID | |||||
| 125809131 | 12580913 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125809131 | 12580913 | 4 | C | RESTASIS | CYCLOSPORINE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125809131 | 12580913 | 1 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125809131 | 12580913 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125809131 | 12580913 | 1 | 2011 | 0 | ||
| 125809131 | 12580913 | 2 | 2011 | 0 |